ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,658, issued on April 8, was assigned to CLEXIO BIOSCIENCES LTD. (Yokne'am, Israel).
"Dosage regime with esketamine for treating major depressive disorder" was invented by Johanna Schumann (Jerusalem) and Dorit Mimrod (Jerusalem).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for safe and efficacious administration of esketamine."
The patent was filed on Dec. 29, 2020, under Application No. 17/789,631.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PT...